These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2126880)

  • 1. [Cost-benefit analysis of amniocentesis in the prenatal diagnosis of chromosome abnormalities].
    Moatti JP; Le Gales C; Julian C; Lanoe JL; Ayme S
    Rev Epidemiol Sante Publique; 1990; 38(4):309-21. PubMed ID: 2126880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal cytogenetic diagnosis: medical and social implications. Indications, acceptance by doctors and patients, impact and cost: a 10-year review.
    Bell JA; Pearn JH
    Med J Aust; 1985 Jul; 143(2):76-9. PubMed ID: 3160918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical approach to prenatal diagnosis of chromosome abnormalities].
    Herlicoviez M
    Reprod Nutr Dev; 1990; Suppl 1():139s-145s. PubMed ID: 2206291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal cytogenetic diagnosis--a current audit. A review of 2000 cases of prenatal cytogenetic diagnoses after amniocentesis, and comparisons with early experience.
    Bell JA; Pearn JH; Wilson BH; Ansford AJ
    Med J Aust; 1987 Jan; 146(1):12-5. PubMed ID: 3796389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics, amniocentesis, and abortion.
    Hirschhorn K
    Mt Sinai J Med; 1984; 51(1):15-7. PubMed ID: 6608672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Data obtained by prenatal diagnosis of maternal age dependence of fetal chromosomal anomalies].
    Szemere G; Faragó M; Szabó J; Hetényi M
    Orv Hetil; 1991 Dec; 132(51):2845-9. PubMed ID: 1837074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal cytogenetic diagnosis in older pregnant women].
    Kalina I; Ondrusseková A; Lukacín S; Konecná H; Fialová B; Herman M
    Cesk Gynekol; 1993 Dec; 58(6):283-5. PubMed ID: 8293504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fetal malformations and chromosome abnormalities diagnosed at the Center of Prenatal Diagnosis of the University of Aquila in the 1995-1998 triennium].
    Carta G; Iovenitti P; D'Alfonso A; Mascaretti G; Moscarini M
    Minerva Ginecol; 1999 Oct; 51(10):393-8. PubMed ID: 10638165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromosome abnormalities: known risk factors].
    Ayme S; Mattei JF; Mattei MG; Giraud F
    J Genet Hum; 1980 Sep; 28(3):155-78. PubMed ID: 6450823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cordocentesis versus amniocentesis for rapid fetal karyotyping in cases of late referral of women.
    Boulot P; Lefort G; Bachelard B; Humeau C; Hedon B; Laffargue F; Viala JL
    J Perinat Med; 1992; 20(2):159-61. PubMed ID: 1501060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis in 3,000 women for chromosome, X-linked, and metabolic disorders.
    Daniel A; Stewart L; Saville T; Brookwell R; Paull H; Purvis-Smith S; Lam-Po-Tang PR
    Am J Med Genet; 1982 Jan; 11(1):61-75. PubMed ID: 7065004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prenatal cytogenetic diagnosis in the 2d trimester in older pregnant women].
    Subrt I; Benesová O; Stirská K; Zwinger A
    Cesk Gynekol; 1989 Nov; 54(9):677-80. PubMed ID: 2533885
    [No Abstract]   [Full Text] [Related]  

  • 15. [Economic analysis of the dissemination of a medical innovation: prenatal diagnosis by early amniocentesis as an example. Part 2. Facilitating decision making in public health for optimal dissemination of an innovation].
    Gardent H; Fardeau M; Lanöe JL; Kerleau M
    Rev Epidemiol Sante Publique; 1984; 32(2):97-106. PubMed ID: 6237394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost utility of prenatal diagnosis and the risk-based threshold.
    Harris RA; Washington AE; Nease RF; Kuppermann M
    Lancet; 2004 Jan; 363(9405):276-82. PubMed ID: 14751700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results.
    Valerio D; Aiello R; Altieri V; Fagnoni P
    Minerva Ginecol; 1996 May; 48(5):169-73. PubMed ID: 8783867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis in 350 amniocenteses].
    Grether P; Zavaleta MJ; de la Luna E; Sánchez-Solis V; Hernández C; Karchmer S
    Ginecol Obstet Mex; 1991 Nov; 59():317-22. PubMed ID: 1797616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
    Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P
    J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.